本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

3.53
+0.02000.57%
盘前3.530.00000.00%05:48 EDT
成交量:91.33万
成交额:319.09万
市值:3.88亿
市盈率:-20.76
高:3.55
开:3.53
低:3.38
收:3.51
52周最高:5.45
52周最低:2.53
股本:1.10亿
流通股本:8,496.03万
量比:0.75
换手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
净资产收益率:-4.77%
总资产收益率:-28.42%
市净率:1.05
市盈率(LYR):-1.76

数据加载中...

2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities